Part: 12         Session: 145678910111213141516171819202122         Page 599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663 of 999

and it tells whether it's fast or slow-growing. He says. We'll see. By a year from now, we ought to know this.

How long has he been working on this?

Quite a while. Did you have any other questions?

Not in the area of cancer, I don't have any. Perhaps I might comment and say, are there any really new developments in the area of chemotherapy?

Well, yes. There's this drug called AD-32, which is a new form of adriamycin.

You mentioned, could possibly be for --

Yes, and a new drug that is being tested in animals, called PALA, which Dr. Vita is very enthusiastic about. In animals, but it won't be available for humans for six months, he says.

What effect does it have, do they hope?

They say it covers, that is treats a large number of a great variety of tumors in animals, and that it's not toxic. So that's, of course, what's necessary, but what happens in the transmission from animals to humans is still to be found out.

Since this has been in the press so much, what is the attitude of your friends in the area of laetril?

Of laetril?

Yes, laetril.